NCT05247970View on ClinicalTrials.gov

A Study to Assess S-309309 in Healthy and Obese Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

74

Participants

Timeline

Start Date

January 4, 2022

Primary Completion Date

October 20, 2022

Study Completion Date

November 1, 2022

Conditions
Obesity
Interventions
DRUG

S-309309

Capsule administered orally

DRUG

Midazolam

Syrup administered orally

DRUG

Placebo

Matching capsule to S-309309 administered orally

Trial Locations (1)

78209

ICON Early Phase Services, LLC, San Antonio

Sponsors

Lead Sponsor

Shionogi
All Listed Sponsors
lead

Shionogi

INDUSTRY

NCT05247970 - A Study to Assess S-309309 in Healthy and Obese Participants | Biotech Hunter | Biotech Hunter